Skip to content

10x Genomics

US · TXG #1311 by market cap Listed 2019
51.80 -5.58 -9.72%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About 10x Genomics

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Founded
2012
CEO
Dr. Serge Saxonov, PhD
Employees
1,178
Headquarters
Pleasanton, California, United States of America
Fiscal year end
12-31
Website
10xgenomics.com

Company profile

Exchange
US
Symbol
TXG
Market-cap rank
#1311
Listing date
2019-09-12
Market cap
6.81B
Float cap
6.19B
Shares out
131.53M
Float shares
119.47M

Sectors & themes

ARK Portfolio AI medical concept stocks Medical Devices Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

10x Genomics discussion 0 comments

Add a comment